CN103751489A - Postoperative medicament for neurosurgery and preparation method for postoperative medicament - Google Patents
Postoperative medicament for neurosurgery and preparation method for postoperative medicament Download PDFInfo
- Publication number
- CN103751489A CN103751489A CN201410044147.0A CN201410044147A CN103751489A CN 103751489 A CN103751489 A CN 103751489A CN 201410044147 A CN201410044147 A CN 201410044147A CN 103751489 A CN103751489 A CN 103751489A
- Authority
- CN
- China
- Prior art keywords
- postoperative
- radix
- parts
- pain
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 230000002980 postoperative effect Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 240000001668 Ficus lacor Species 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000341 volatile oil Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 4
- 238000005507 spraying Methods 0.000 claims abstract description 4
- 238000001256 steam distillation Methods 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims description 26
- 235000012239 silicon dioxide Nutrition 0.000 claims description 14
- 241001264480 Lycopodiastrum casuarinoides Species 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 208000004550 Postoperative Pain Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 235000013399 edible fruits Nutrition 0.000 abstract description 5
- 244000291333 Serissa japonica Species 0.000 abstract description 4
- 244000025221 Humulus lupulus Species 0.000 abstract description 3
- 235000008694 Humulus lupulus Nutrition 0.000 abstract description 3
- 244000036905 Benincasa cerifera Species 0.000 abstract description 2
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract description 2
- 240000004274 Sarcandra glabra Species 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 235000009467 Carica papaya Nutrition 0.000 abstract 2
- 241000219172 Caricaceae Species 0.000 abstract 2
- 241000244987 Daiswa polyphylla Species 0.000 abstract 2
- 241001504070 Huperzia Species 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- 239000011259 mixed solution Substances 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 38
- 239000002775 capsule Substances 0.000 description 10
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 108091006146 Channels Proteins 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000000929 nociceptor Anatomy 0.000 description 6
- 108091008700 nociceptors Proteins 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 241001464409 Benincasa Species 0.000 description 5
- 235000011273 Benincasa Nutrition 0.000 description 5
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 5
- 241000736026 Sarcandra Species 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 3
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000001473 noxious effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 241000218231 Moraceae Species 0.000 description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 208000021722 neuropathic pain Diseases 0.000 description 2
- 229960003753 nitric oxide Drugs 0.000 description 2
- 230000008058 pain sensation Effects 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 229910052567 struvite Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000510531 Angelica decursiva Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 240000000425 Chaenomeles speciosa Species 0.000 description 1
- 241000758719 Chloranthaceae Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 241001450685 Corallium japonicum Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000003537 Ficus benghalensis Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010065952 Hyperpathia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 241000195947 Lycopodium Species 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241001254606 Peucedanum praeruptorum Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000010842 Sarcandra glabra Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000008675 zhuhuang Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a postoperative medicament for neurosurgery and a preparation method for the postoperative medicament. The preparation method is characterized by comprising the following steps: (1) extracting volatile oil from ficus virens, tabasheer, Chinese waxgourd seeds, glabrous sarcandra herb, beefwood-like clubmoss herb and radix platycodi coarse powder by using a steam distillation method respectively, collecting and mixing the volatile oil for standby, and remaining residues for use; (2) uniformly mixing paris polyphylla, serissa serissoides, radix peucedani, dark plum fruits, humulus lupulus, papayas and the residues obtained in the step 1, adding water with the amount 10 times of the total amount of the paris polyphylla, the serissa serissoides, the radix peucedani, the dark plum fruits, the humulus lupulus, the papayas and the residues obtained in the step 1, performing decoction twice for 1 hour each time, mixing decoction, standing the mixed decoction, adding 95 percent ethanol with the amount 3 to 4 times of that of liquid medicine into the decoction, standing the mixed solution for 15 minutes, performing centrifugation for 20 minutes at speed of 3,000rpm/min, extracting clear liquid, and performing concentration and spray drying to obtain an initial material; (3) spraying the volatile oil obtained in the step (1) into the initial material obtained in the step (3), enabling the initial material to pass through a 60-mesh sieve, and performing capsulation. Clinical experiments show that the postoperative medicament can be used for relieving postoperative pain, and has the characteristics of good curative effects, high safety and high clinical application and popularization value.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to postoperative medication of a kind of neurosurgery and preparation method thereof.
Background technology
Pain (Pain) is a kind of and tissue injury or potential relevant offending subjective sensation and the emotional experience of damage.It comprises to keenly feel feels and bitterly reacts two compositions, and pain feel refers to the sensation of the mankind to pain, is that the mankind are peculiar.Alarm signal when pain can provide body to be on the hazard, promptly reacts body to noxious stimulation.Pathological pain can be divided into again struvite pain and neuropathic pain according to the difference of cause, and they all can produce at body and viscera tissue.Struvite pain refers to the pain that the peripheral tissues's damage being caused by wound, antibacterial or viral infection and surgical operation occurs while causing inflammation, comprises hyperpathia, touches and bring out pain, spontaneous pain and secondary pain.Neuropathic pain refers to the nerve injury being caused by wound, infection or metabolic disease and the pain causing.Neurosurgery postoperative pain is related with the two.
Recent study shows, there is " postoperative pain hypersensitive state " in the postoperative meeting of neurosurgery, this kind of state factor that starts is various, with nmda receptor high expressed, nitric oxide is relevant with nitricoxide synthase and maincenter inflammatory reaction, also relevant with operation local neural tissue tractive in art.This kind of hypersensitive state and damaging pain are irrelevant, the former is threshold of pain reduction in particular cases, latter mostly is the optimum reaction that the nociceptor (nociceptor) that is distributed widely in skin, muscle, joint and internal organs produces multiple noxious stimulation of different nature (chemical, mechanical, scorching hot etc.), and the impulsion of nociceptor activates central nervous system and causes pain sensation induction.So this kind of situation used analgesic after surgery, tends to cover the state of an illness, and be unfavorable for that local nerve recovers.
Summary of the invention
Technical assignment of the present invention is for above the deficiencies in the prior art, and postoperative medication of neurosurgery that a kind of curative effect is affirmed and side effect is little and preparation method thereof is provided.
The technical scheme that the present invention solves its technical problem is: a kind of medicine for the treatment of hypersensitive state after neurosurgery, is characterized in that being prepared from by the crude drug of following weight proportion: 10 ~ 30 parts of Folium fici wightianae (Ficus wightiana Wall)s, 6 ~ 12 parts of Herba Sarcandraes, 3 ~ 10 parts of Concretio silicea Bambusae seu schizostachyis, 6 ~ 12 parts of Rhizoma Paridis, 3 ~ 10 parts of Radix Platycodoniss, 6 ~ 12 parts of Radix Peucedanis, 6 ~ 12 parts of Semen Benincasaes, 6 ~ 12 parts of Flos lupuli (Flos Humuli Lupuli)s, 6 ~ 12 parts of Fructus Mumes, 1 ~ 5 part of Lycopodium casuarinoides Spring, 3 ~ 10 parts of Fructus Chaenomeliss, 10 ~ 25 parts of Radix Serissae.
Chinese medicine of the present invention can be prepared from by following method:
(1) by Folium fici wightianae (Ficus wightiana Wall), Concretio silicea Bambusae seu schizostachyi, Semen Benincasae, Herba Sarcandrae, Lycopodium casuarinoides Spring, Radix Platycodonis coarse powder respectively with extraction by steam distillation volatile oil, and collect after mixing for standby use, medicinal residues are continued to employ;
(2) Rhizoma Paridis, Radix Serissae, Radix Peucedani, Fructus Mume, Flos lupuli (Flos Humuli Lupuli), Fructus Chaenomelis, and in step 1, gained medicinal residues mix and add 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, standing; Then toward 95% the ethanol that adds 3 ~ 4 times of medicinal liquids in decocting liquid, standing 15 minutes, then with 3000rpm/min centrifugal 20 minutes, get clear liquid, concentrated after spraying dry, draw just material;
(3) gained volatile oil in step 1 is sprayed in the first material of step 3 gained, cross 60 mesh sieves, encapsulated forming.
Wherein said: Folium fici wightianae (Ficus wightiana Wall) is moraceae plants shaft of a writing brush banyan Ficus virens Ait .[F.wightana (Miq.)] leaf of Benth..Sweet in the mouth; Micro-hardship; Property is put down.Merit can heat-clearing and toxic substances removing; Removing damp to relieve itching.
Herba Sarcandrae is the dry Herb of Chloranthaceae plant plait Corallium Japonicum Kishinouye Sarcandra glabra (Thunb.) Nakai.Bitter, pungent, flat.GUIXIN, Liver Channel.Merit can clearing away heat and cooling blood, the speckle removing of invigorating blood circulation, dispelling wind and removing obstruction in the collateral.
Concretio silicea Bambusae seu schizostachyi, for Mycophyta Ascomycetes Rou Zuo section Concretio silicea Bambusae seu schizostachyi belongs to Fungus Zhuhuang Stroma.Light, flat.Merit can expelling wind and removing dampness, the easypro warp of invigorating blood circulation, cough-relieving.
Rhizoma Paridis is the rhizome of liliaceous plant Rhizoma Paridis.Hardship, is slightly cold.Enter Liver Channel.Merit can heat-clearing and toxic substances removing, detumescence, spasmolytic.
Radix Platycodonis is Campanulaceae Radix Platycodonis Platycodon grandiflorum(Jacq.) dry root of A.DC..Nature and flavor hardship, pungent, flat.Return lung meridian.Merit can lung qi dispersing, and sore-throat relieving, eliminates the phlegm, evacuation of pus.
Radix Peucedani is the dry root of samphire Peucedanum praeruptorum DUNN Peucedanum praeruptorum Dunn or RADIX PEUCEDANI Peucedanum decursivum Maxim..Nature and flavor hardship, pungent, is slightly cold.Return lung meridian.The merit wind heat clearing away of can faling apart, lowering the adverse-rising QI to resolve phlegm.
Semen Benincasae is Cucurbitaceae herbaceous plant Fructus Benincasae Benincasahispida(Thumb.) seed of Cogn..Nature and flavor are sweet, cold.Return spleen, stomach, large intestine, small intestine meridian.Function lung heat clearing, reduce phlegm, evacuation of pus.
Flos lupuli (Flos Humuli Lupuli) is the green fruit ear of immaturity of Moraceae humulus plants Flos lupuli (Flos Humuli Lupuli) Humulus lupulus L..Bitter in the mouth; Slightly cool in nature.Return liver; Stomach warp.Merit can invigorating the stomach and promoting digestion; Inducing diuresis to remove edema; Anti-consumptive disease antiinflammatory.
Fructus Mume is the dry almost ripe fruit of rose department plant plum.Sour, puckery, flat.Return liver, spleen, lung, large intestine channel.Merit can be astringed the lung, and astringing intestine to stop diarrhea promotes the production of body fluid, relieving colic caused by ascaris.
Lycopodium casuarinoides Spring, for fern Lycopodiaceae Lycopodium phytobezoar Lycopodium casuarinoides, with all herbal medicine.Micro-sweet, temperature.Merit can relaxing muscles and tendons to promote blood circulation, wind-damp dispelling.
Fructus Chaenomelis is the dry almost ripe fruit of rosaceous plant chaenomeles lagenaria.Acid, temperature.Return liver, spleen channel.Merit can suppressing the hyperactive liver relaxing muscles and tendons, stomach function regulating removing dampness.
Radix Serissae is the herb strain of dicotyledon medicine Maguireothamnus speciosus Radix Serissae Serissa serissoides (DC.) Druce or Serissa foetida Serissa japonica (Thunb.) Thunb..Nature and flavor toil; Cool; Nontoxic.Return liver; Spleen channel.Merit can be dispeled the wind; Dampness removing; Heat clearing away; Removing toxic substances.
Composition principle: neurosurgery postoperative " postoperative pain hypersensitive state ", with nmda receptor high expressed, nitric oxide is relevant with nitricoxide synthase and maincenter inflammatory reaction, also relevant with operation local neural tissue tractive in art.This kind of hypersensitive state and damaging pain are irrelevant, the former is threshold of pain reduction in particular cases, latter mostly is the optimum reaction that the nociceptor (nociceptor) that is distributed widely in skin, muscle, joint and internal organs produces multiple noxious stimulation of different nature (chemical, mechanical, scorching hot etc.), and the impulsion of nociceptor activates central nervous system and causes pain sensation induction.So this kind of situation used analgesic after surgery, tends to cover the state of an illness, and be unfavorable for that local nerve recovers.Inventor's clinical research finds, neurosurgery postoperative " postoperative pain hypersensitive state " is relevant with the pathogenic wind toxic phlegm-fire among meridians, and the pathogenic wind toxic phlegm-fire channels of burning, causes pain hypersensitive state.
Compared with prior art, the present invention has following characteristics:
1, prescription uniqueness: get Folium fici wightianae (Ficus wightiana Wall), Herba Sarcandrae in side for monarch, described Folium fici wightianae (Ficus wightiana Wall) coordinates with Herba Sarcandrae, for the pathogenic wind toxic phlegm-fire among network after neurosurgery operation; The constriction experiment of rat nerve root confirms: the water extraction liquid of 10mg/kg Folium fici wightianae (Ficus wightiana Wall) and Herba Sarcandrae has can reduce postoperative nmda receptor expression;
2, in side, get Concretio silicea Bambusae seu schizostachyi, Lycopodium casuarinoides Spring, Fructus Chaenomelis relaxing muscles and tendons, Rhizoma Paridis removing toxic substances spasmolytic, Flos lupuli (Flos Humuli Lupuli) emergency, above five tastes medicine is alleviated this postoperative hypersensitive state from meridians angle, the neutral stretch producing in art with antagonism, the spasm that Concretio silicea Bambusae seu schizostachyi extract can antagonism acetylcholine causes, has skeletal muscle relaxation effect;
3, Radix Platycodonis, Radix Peucedani, Semen Benincasae remove the expectorant of meridians;
4, get Fructus Mume simply and hold back puckery using corrigent, prevent postoperative pungently and wander away, and Fructus Mume convergence and the property of medicine is steady, can not cause that local venation is not all right and impact recovers;
5, Radix Serissae expelling wind and removing dampness; Heat-clearing and toxic substances removing is supplementary drug thing;
6, medicine material consumption of the present invention is groped in a large number to sum up through inventor and is drawn, each raw material consumption is for all to have good curative effect in following weight parts scope.
The specific embodiment
Below in conjunction with practical situation, the specific embodiment of the present invention is elaborated.
Embodiment 1, crude drug weight proportion: 20 parts of Folium fici wightianae (Ficus wightiana Wall)s, 10 parts of Herba Sarcandraes, 6 parts of Concretio silicea Bambusae seu schizostachyis, 10 parts of Rhizoma Paridis, 6 parts of Radix Platycodoniss, 10 parts of Radix Peucedanis, 10 parts of Semen Benincasaes, 10 parts of Flos lupuli (Flos Humuli Lupuli)s, 10 parts of Fructus Mumes, 2 parts of Lycopodium casuarinoides Springs, 6 parts of Fructus Chaenomeliss, 20 parts of Radix Serissae.
The preparation method of embodiment 1 is: Folium fici wightianae (Ficus wightiana Wall), Herba Sarcandrae, Concretio silicea Bambusae seu schizostachyi, Rhizoma Paridis, Radix Platycodonis, Radix Peucedani, Semen Benincasae, Flos lupuli (Flos Humuli Lupuli), Fructus Mume, Lycopodium casuarinoides Spring, Fructus Chaenomelis, Radix Serissae mixing and water adding are decocted, after 30 minutes, get filtrate, medicinal residues add water continuation decoction and get filtrate after 20 minutes, twice filtrate merges, and is divided into two parts of morning and evenings to take.
Embodiment 2, crude drug weight proportion: 10 parts of Folium fici wightianae (Ficus wightiana Wall)s, 6 parts of Herba Sarcandraes, 3 parts of Concretio silicea Bambusae seu schizostachyis, 6 parts of Rhizoma Paridis, 3 parts of Radix Platycodoniss, 6 parts of Radix Peucedanis, 6 parts of Semen Benincasaes, 6 parts of Flos lupuli (Flos Humuli Lupuli)s, 6 parts of Fructus Mumes, 1 part of Lycopodium casuarinoides Spring, 3 parts of Fructus Chaenomeliss, 10 parts of Radix Serissae.
Embodiment 3, crude drug weight proportion: 20 parts of Folium fici wightianae (Ficus wightiana Wall)s, 10 parts of Herba Sarcandraes, 6 parts of Concretio silicea Bambusae seu schizostachyis, 10 parts of Rhizoma Paridis, 6 parts of Radix Platycodoniss, 10 parts of Radix Peucedanis, 10 parts of Semen Benincasaes, 10 parts of Flos lupuli (Flos Humuli Lupuli)s, 10 parts of Fructus Mumes, 2 parts of Lycopodium casuarinoides Springs, 6 parts of Fructus Chaenomeliss, 20 parts of Radix Serissae.
Embodiment 4, crude drug weight proportion: 30 parts of Folium fici wightianae (Ficus wightiana Wall)s, 12 parts of Herba Sarcandraes, 10 parts of Concretio silicea Bambusae seu schizostachyis, 12 parts of Rhizoma Paridis, 10 parts of Radix Platycodoniss, 12 parts of Radix Peucedanis, 12 parts of Semen Benincasaes, 12 parts of Flos lupuli (Flos Humuli Lupuli)s, 12 parts of Fructus Mumes, 5 parts of Lycopodium casuarinoides Springs, 10 parts of Fructus Chaenomeliss, 25 parts of Radix Serissae.
The Chinese medicine of embodiment 2 ~ 4 can be prepared from by following method:
(1) by Folium fici wightianae (Ficus wightiana Wall), Concretio silicea Bambusae seu schizostachyi, Semen Benincasae, Herba Sarcandrae, Lycopodium casuarinoides Spring, Radix Platycodonis coarse powder respectively with extraction by steam distillation volatile oil, and collect after mixing for standby use, medicinal residues are continued to employ;
(2) Rhizoma Paridis, Radix Serissae, Radix Peucedani, Fructus Mume, Flos lupuli (Flos Humuli Lupuli), Fructus Chaenomelis, and in step 1, gained medicinal residues mix and add 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, standing; Then toward 95% the ethanol that adds 3 ~ 4 times of medicinal liquids in decocting liquid, standing 15 minutes, then with 3000rpm/min centrifugal 20 minutes, get clear liquid, concentrated after spraying dry, draw just material;
(3) gained volatile oil in step 1 is sprayed in the first material of step 3 gained, cross 60 mesh sieves, encapsulated forming.
Can set every capsules is 1g.
Effective combination of said medicine, coordinates mutually, effectively reach the object of alleviating postoperative pain, and side effect is less.The above results is that clinical data fully proves, interrelated data is as follows.
1 object and method.
1.1 objects: in January, 2011 ~ 2013 neurosurgery operation on peripheral nerve patient 96 examples in year June, its midbrain operation on peripheral nerve 21 examples, limb operation 75 examples, emergency treatment wound is repaired 32 examples, 64 examples of choosing date for operation; Man's 59 examples, female's 37 examples, age 15 ~ 65(34.32 ± 12.71) year; Be divided into matched group 32 examples, decoction group 30 examples and Capsules group 34 examples, before three groups of patient treatments, on sex, age, the state of an illness, operating time, compare, difference not statistically significant (P>0.05), has comparability.
1.2 method.
1.2.1 Therapeutic Method: after postoperative 6h, matched group oryzanol, 30mg/ time, 3 times/d, warm water takes.Decoction group is with gained decoction oral in the embodiment of the present invention 1,2 times/d.Capsules group is with gained capsule oral in the embodiment of the present invention 2,3g/ time, 2 times/d.7d was 1 course for the treatment of, after 1 course for the treatment of, added up curative effect.
1.2.2 pain intensity: by patient's judgement, 0～10 digital pain intensity staging (NPIS), record 0～2 is without pain, and 3～5 is mild pain, and 6～7 is moderate pain, and 8～10 is severe pain.
1.2.3 pain relief degree (PAR): judge record according to patient's pain relief degree by 5 grades by doctor.0 degree, does not alleviate; 1 degree is slight alleviates (pain relief is about 1/4); 2 degree, moderate is alleviated (pain relief is about 1/2); 3 degree, obviously alleviate (pain relief is more than 3/4); 4 degree, pain disappears.
1.2.4 safety monitoring index before patient takes medicine in detail inquiry have or not dizzy, nauseating, vomiting, nervous, uncomfortable in chest, breathe hard, drowsiness, erythra, the symptom such as weak all over the body.Go forward side by side promoting the circulation of blood pressure, pulse, breathing and pupil examination, 7d detects liver function, kidney merit, routine blood test and routine urinalysis before taking medicine and after medication simultaneously.
1.2.5 analgesic effect evaluation index: pain intense difference (PID) be before patient takes medicine pain intensity with take medicine after measure the difference of pain intensity.
1.2.6 statistical analysis: SPSS 13.0 carries out statistical analysis.Measurement data is checked with t, enumeration data χ
2check.
2 results.
2.1 medication first three groups pain situation comparisons: during postoperative 6h, three groups of pain intensities are respectively: matched group 6.20 ± 0.85, decoction group 6.65 ± 1.01, Capsules group 6.38 ± 1.12.Three groups of comparisons, group difference not statistically significant (P>0.05).
After 2.2 postoperative 3d, still demand wants analgesic (somedon sheet) to be respectively by lenitive case load: matched group 12 examples, decoction group 4 examples, Capsules group 5 examples.Three groups of comparisons, decoction group, Capsules group analgesics are used and are starkly lower than matched group (P<0.05).
Three groups of pain situations comparison after 2.3 medication 7d: reject in three days for three groups and used after the patient of analgesic (somedon sheet), three groups of pain intensities are respectively: matched group 4.67 ± 1.09, decoction group 3.26 ± 1.03, Capsules group 3.62 ± 0.88.Three groups of comparisons, decoction group, Capsules group pain situation are starkly lower than matched group (P<0.05).2.4 3 groups of adverse reactions of patients incidence rates comparison: three groups obvious adverse reaction does not all occur.
3. conclusion.
This result of study shows, take decoction group of the present invention and Capsules group postoperative pain situation is obviously better than matched group, can effectively reduce the use of analgesic, and without obvious adverse reaction, illustrate that pharmaceutical composition prepared by the inventive method has that untoward reaction is light, the higher advantage of safety aspect postoperative pain alleviating.
Claims (1)
1. kind of postoperative medication of neurosurgery and preparation method thereof, is characterized in that: raw material comprises Folium fici wightianae (Ficus wightiana Wall), Herba Sarcandrae, Concretio silicea Bambusae seu schizostachyi, Rhizoma Paridis, Radix Platycodonis, Radix Peucedani, Semen Benincasae, Flos lupuli (Flos Humuli Lupuli), Fructus Mume, Lycopodium casuarinoides Spring, Fructus Chaenomelis, Radix Serissae; By following steps, formed:
(1) by Folium fici wightianae (Ficus wightiana Wall), Concretio silicea Bambusae seu schizostachyi, Semen Benincasae, Herba Sarcandrae, Lycopodium casuarinoides Spring, Radix Platycodonis coarse powder respectively with extraction by steam distillation volatile oil, and collect after mixing for standby use, medicinal residues are continued to employ;
(2) Rhizoma Paridis, Radix Serissae, Radix Peucedani, Fructus Mume, Flos lupuli (Flos Humuli Lupuli), Fructus Chaenomelis, and in step 1, gained medicinal residues mix and add 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, standing; Then toward 95% the ethanol that adds 3 ~ 4 times of medicinal liquids in decocting liquid, standing 15 minutes, then with 3000rpm/min centrifugal 20 minutes, get clear liquid, concentrated after spraying dry, draw just material;
(3) gained volatile oil in step 1 is sprayed in the first material of step 3 gained, cross 60 mesh sieves, encapsulated forming.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410044147.0A CN103751489B (en) | 2014-01-30 | 2014-01-30 | A kind of preparation method for the treatment of the postoperative pain medication of neurosurgery |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410044147.0A CN103751489B (en) | 2014-01-30 | 2014-01-30 | A kind of preparation method for the treatment of the postoperative pain medication of neurosurgery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103751489A true CN103751489A (en) | 2014-04-30 |
| CN103751489B CN103751489B (en) | 2016-04-13 |
Family
ID=50518916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410044147.0A Expired - Fee Related CN103751489B (en) | 2014-01-30 | 2014-01-30 | A kind of preparation method for the treatment of the postoperative pain medication of neurosurgery |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103751489B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825578A (en) * | 2015-04-28 | 2015-08-12 | 刘昆 | Drug for promoting recovery after facial nerve injury surgery anastomosis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526433A (en) * | 2012-01-31 | 2012-07-04 | 赵海霞 | Medicine for treating articular contracture |
| CN102614323A (en) * | 2012-04-20 | 2012-08-01 | 李凤荣 | Method for preparing atomized liquid for treating infantile asthmatic suffocating pneumonia |
| CN102698068A (en) * | 2012-07-02 | 2012-10-03 | 张秀香 | Preparation method for oral nursing solution for preventing oral mucositis caused by chemotherapy |
-
2014
- 2014-01-30 CN CN201410044147.0A patent/CN103751489B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526433A (en) * | 2012-01-31 | 2012-07-04 | 赵海霞 | Medicine for treating articular contracture |
| CN102614323A (en) * | 2012-04-20 | 2012-08-01 | 李凤荣 | Method for preparing atomized liquid for treating infantile asthmatic suffocating pneumonia |
| CN102698068A (en) * | 2012-07-02 | 2012-10-03 | 张秀香 | Preparation method for oral nursing solution for preventing oral mucositis caused by chemotherapy |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825578A (en) * | 2015-04-28 | 2015-08-12 | 刘昆 | Drug for promoting recovery after facial nerve injury surgery anastomosis |
| CN104825578B (en) * | 2015-04-28 | 2019-06-04 | 刘昆 | A kind of drug promoting the postoperative rehabilitation of facial nerve injury surgical stapling |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103751489B (en) | 2016-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102283999A (en) | Traditional Chinese medicine preparation for treating insomnia | |
| CN105079757A (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN102908391B (en) | Chinese medicinal composition for treating dermatosis and preparation method and application thereof | |
| CN102716334B (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
| CN103211990A (en) | Chinese medicinal composition for treating oral ulcer | |
| CN103316250B (en) | Traditional Chinese medicine composition for treating cardiopalmus | |
| CN103007214B (en) | Chinese medicinal composition for treating palpitation | |
| CN103768408B (en) | A kind of medicine preventing and treating anal and intestinal disease postoperative pain | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN103751489B (en) | A kind of preparation method for the treatment of the postoperative pain medication of neurosurgery | |
| CN103751488B (en) | A kind of medicine for the treatment of high-sensitivity condition after neurosurgery operation | |
| CN105477330A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN105560736A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN104971302A (en) | Traditional Chinese medicine composition for treating biliary tract ascariasis | |
| CN104666689A (en) | Medicine for treating hypertension | |
| CN104353043A (en) | Traditional Chinese medicine composition for treating dawn diarrhea and preparation method thereof | |
| CN104055959A (en) | Traditional Chinese medicine lotion and nursing method for treating gastrointestinal dampness-heat type seborrhoeic dermatitis | |
| CN103860914A (en) | Chinese medicine composition for treating epilepsy | |
| CN103656591A (en) | Chinese herbal preparation for treating angioneurotic headache | |
| CN103735868B (en) | A kind of preparation method of anal and intestinal disease postoperative bag | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
| CN105079514A (en) | Traditional Chinese medicine composition for treating dizziness | |
| CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yu Zongguang Inventor after: Sun Xiaoyan Inventor before: Gao Zhimin Inventor before: Zheng Hongcai Inventor before: Xu Xisheng Inventor before: Wang Chunai |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160314 Address after: 266214 Department of cerebral surgery, Jimo Second People's Hospital of Jimo City, Shandong, Qingdao Applicant after: Yu Zongguang Address before: 262200 Zhucheng people's Hospital, 59 South Outer Ring Road, Zhucheng, Shandong, Weifang Applicant before: Gao Zhimin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181022 Address after: 401120 Chongqing Yubei District Shuangfeng Bridge Street Airport Development Zone Xiangyu Road 15, 1 1 stories. Patentee after: CHONGQING TIANYI HENGHUA TECHNOLOGY CO., LTD. Address before: 266214 Department of cerebral surgery, Jimo Second People's Hospital, Dian Ji Town, Jimo City, Qingdao, Shandong, China Patentee before: Yu Zongguang |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160413 Termination date: 20190130 |